Media Newsroom of

First Light Diagnostics

Follow on Social Network

First Light Diagnostics, formerly First Light Biosciences is developing breakthrough automated medical diagnostic products for rapid, sensitive, and cost-effective detection of Healthcare Associated Infections (HAI).

Dr. Melvin Weinstein Becomes a Member of First Light Diagnostics Clinical Advisory Board

Dr. Melvin Weinstein Becomes a Member of First Light Diagnostics Clinical Advisory Board

​First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced the addition of Melvin P. Weinstein, M.D., to the company’s world-class, international Clinical Advisory Board. “Dr. Weinstein is a recognized…

First Light Diagnostics Joins Global Initiative to Combat Antibiotic Resistance

First Light Diagnostics Joins Global Initiative to Combat Antibiotic Resistance

 First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced their participation in the U.S. Centers for Disease Control and Prevention (CDC) Antimicrobial Resistance (AMR) Challenge. First Light’s MultiPath™ platform…

First Light Diagnostics CEO David Macdonald to Present at BIO Investor Forum

First Light Diagnostics CEO David Macdonald to Present at BIO Investor Forum

First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced that First Light’s CEO, David Macdonald, will be among the presenters at the 2019 BIO Investor Forum. The BIO…

Dr. Angela Caliendo Joins First Light Diagnostics Clinical Advisory Board

Dr. Angela Caliendo Joins First Light Diagnostics Clinical Advisory Board

​​​First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced the addition of Angela M. Caliendo, M.D., Ph.D., to the company’s world-class, international clinical advisory board. “Angie’s expertise and…

Dr. Joanne Spadoro Joins First Light Diagnostics

Dr. Joanne Spadoro Joins First Light Diagnostics

​First Light Diagnostics, Inc., a developer of breakthrough automated products for rapid, sensitive and cost-effective diagnosis and treatment of life-threatening, antibiotic-resistant infections, today announced the addition of Dr. Joanne Spadoro as its Vice President of R&D and Regulatory Affairs. Dr. Spadoro…

First Light Diagnostics MultiPath™ Part of Innovation Alley at IDWeek 2019

First Light Diagnostics MultiPath™ Part of Innovation Alley at IDWeek 2019

First Light Diagnostics, Inc., a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis and treatment of life-threatening, antibiotic-resistant infections, today announced their participation at IDWeek 2019 from Oct. 2 – 6 in Washington, DC. First Light Diagnostics…

First Light Diagnostics MultiPath™ Platform to Be Showcased at AACC 2019

First Light Diagnostics MultiPath™ Platform to Be Showcased at AACC 2019

​First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced their participation at the American Association for Clinical Chemistry’s (AACC) 71st Annual Scientific Meeting & Clinical Lab Expo in…

First Light Diagnostics Receives Technology Innovation Leader Award at Frost & Sullivan Gala

First Light Diagnostics Receives Technology Innovation Leader Award at Frost & Sullivan Gala

First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, formally received their award for Technology Innovation at the 2019 Frost & Sullivan Excellence in Best Practices Awards Gala on July…

First Light Adds New Multimedia to Website

First Light Adds New Multimedia to Website

​​First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced the introduction of new multimedia content on the homepage of the First Light Diagnostics website.  The new content offers…

First Light Diagnostics Announces Closing of a $4.5 Million Debt Financing

First Light Diagnostics Announces Closing of a $4.5 Million Debt Financing

First Light Diagnostics Inc., a developer of breakthrough automated products for rapid, sensitive and cost-effective diagnosis and treatment of life-threatening, antibiotic-resistant infections, today announced the closing of a $4.5 million debt financing. This includes a Lease Line with CSC Leasing of Virginia…

First Light Diagnostics to Showcase MultiPath™ Platform at ASM Microbe 2019

First Light Diagnostics to Showcase MultiPath™ Platform at ASM Microbe 2019

 First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced its participation at the American Society for Microbiology's ASM Microbe 2019 Event in San Francisco, California, from June 20-24. First Light…

First Light Diagnostics Welcomes New Vice President of Quality Assurance and Regulatory Affairs

First Light Diagnostics Welcomes New Vice President of Quality Assurance and Regulatory Affairs

​First Light Diagnostics, a developer of breakthrough automated products for the rapid, sensitive and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced the hiring of Andrew Connerty as its vice president of quality assurance and regulatory affairs.        …

First Light Diagnostics Recognized by Frost & Sullivan as Technology Innovation Leader

First Light Diagnostics Recognized by Frost & Sullivan as Technology Innovation Leader

First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced it has been recognized by Frost & Sullivan for best practices in Technology Innovation in the Rapid Diagnostics Industry. Frost…

Dr. Stephen Brecher Joins First Light Diagnostics Clinical Advisory Board

Dr. Stephen Brecher Joins First Light Diagnostics Clinical Advisory Board

First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced the addition of Dr. Stephen Brecher to the company’s world-class, international Clinical Advisory Board. “Stephen is an internationally recognized…

First Light Diagnostics Forms World-Class International Clinical Advisory Board

First Light Diagnostics Forms World-Class International Clinical Advisory Board

First Light Diagnostics, Inc., a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced the establishment of a Clinical Advisory Board (CAB). The board is a growing list of members asked to…

First Light Diagnostics Invited to Speak at Boston Area Antibiotic Resistance Network

First Light Diagnostics Invited to Speak at Boston Area Antibiotic Resistance Network

 First Light Diagnostics, a developer of breakthrough automated diagnostic products for rapid, sensitive and cost-effective diagnostic tests for life-threatening infections, today announced their recent participation at the 6th Annual Meeting of the Boston Area Antibiotic Resistance Network. Don Straus, chief science officer…

First Light Diagnostics Closes $8.25 Million Series A-2 Financing

First Light Diagnostics Closes $8.25 Million Series A-2 Financing

First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced it has closed an oversubscribed $8.25 million Series A-2 financing. The financing includes new investment partners from Think.Health Ventures,…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login